©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 111708
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111708
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111708
Figure 10 Molecular docking diagram of main compounds binding to key target genes.
A: Molecular docking diagram of RELA and orotinin; B: Molecular docking diagram of RELA and morusin; C: Molecular docking diagram of RELA and colchamine; D: Molecular docking diagram of nuclear factor kappa-B inhibitor alpha (NFKBIA) and orotinin; E: Molecular docking diagram of NFKBIA and morusin; F: Molecular docking diagram of NFKBIA and colchamine; G: Molecular docking diagram of NFKB1 and crotinin; H: Molecular docking diagram of NFKB1 and morusin; I: Molecular docking diagram of NFKB1 and colchamine. GLU: Glutamic acid; LYS: Lysine; GLY: Glycine; SER: Serine; THR: Threonine; ASP: Aspartic acid; ASN: Asparagine; ARG: Arginine; GLN: Glutamine; HIS: Histidine; THR: Histidine.
- Citation: Zhang LK, Gu WC, Chen J. Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment. World J Gastroenterol 2025; 31(42): 111708
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/111708.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.111708